A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
American pharmaceutical giant Johnson & Johnson (JNJ) has once again faced rejection on its $10 billion plan to settle thousands of ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
After you’ve gone through ovarian cancer treatment, your doctor will work with you to make sure you stay well. But sometimes the cancer returns. Doctors call this “recurrence.” To check for ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
Ovarian cancer—known as a silent killer due to its inability to showcase most of its symptoms—kills many women every year ...